FDA 重新授权 Swedish Match 的鼻烟为低风险烟草产品，有助于公共卫生。 The FDA reauthorizes Swedish Match's snus as a reduced-risk tobacco product, aiding public health.

林业发展局延长了瑞典对General Snus作为经过修改的 " 风险烟草产品 " 的授权,允许该公司声称使用烟草而不是香烟可以降低诸如口腔癌、心脏病和肺癌等疾病的风险。 The FDA has renewed Swedish Match's authorization for General snus as a Modified Risk Tobacco Product, allowing the company to claim that using it instead of cigarettes reduces risks of diseases like mouth cancer, heart disease, and lung cancer. 这项决定旨在通过向成人吸烟者提供危害较小的烟草选择,使公共健康受益。 This decision aims to benefit public health by offering a less harmful tobacco option to adult smokers.